 Orgenesis NASDAQ:ORGS Inc announced a more than five-fold increase in third-quarter revenue as it continues to roll out its Point of Care POCare platform. The global biotech company, which is focused on unlocking the full potential of cell and gene therapies CGTs, also reported a strong rise in revenue for the first nine months of its financial year to September 30, 2021, to 28.6 million, compared to just 5.3 million for the same period last year. 